These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 16118161

  • 21. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA.
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [Abstract] [Full Text] [Related]

  • 22. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
    Chang YC, Huang YH, Huang CS, Chang PK, Chen JH, Chang RF.
    Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.
    Nunes LW, Schnall MD, Siegelman ES, Langlotz CP, Orel SG, Sullivan D, Muenz LA, Reynolds CA, Torosian MH.
    AJR Am J Roentgenol; 1997 Aug; 169(2):409-15. PubMed ID: 9242744
    [Abstract] [Full Text] [Related]

  • 24. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G, Topal U.
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [Abstract] [Full Text] [Related]

  • 25. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
    Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM.
    AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
    [Abstract] [Full Text] [Related]

  • 26. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
    Schaefer JF, Vollmar J, Schick F, Vonthein R, Seemann MD, Aebert H, Dierkesmann R, Friedel G, Claussen CD.
    Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
    [Abstract] [Full Text] [Related]

  • 27. Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images.
    Mussurakis S, Gibbs P, Horsman A.
    Radiology; 1998 Feb; 206(2):465-73. PubMed ID: 9457201
    [Abstract] [Full Text] [Related]

  • 28. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N, Arslan A, Akansel G, Anik Y, Balci NC, Demirci A.
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [Abstract] [Full Text] [Related]

  • 29. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
    Wang LC, DeMartini WB, Partridge SC, Peacock S, Lehman CD.
    AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
    [Abstract] [Full Text] [Related]

  • 30. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H.
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [Abstract] [Full Text] [Related]

  • 31. Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast.
    Kelcz F, Furman-Haran E, Grobgeld D, Degani H.
    AJR Am J Roentgenol; 2002 Dec; 179(6):1485-92. PubMed ID: 12438042
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP, Makris A, Beresford MJ, Taylor NJ, Ah-See ML, Stirling JJ, d'Arcy JA, Collins DJ, Kozarski R, Padhani AR.
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T, Yuen S, Kasami M, Uchida Y.
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?
    Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH.
    Radiology; 1999 Apr; 211(1):101-10. PubMed ID: 10189459
    [Abstract] [Full Text] [Related]

  • 39. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F, Catalano C, Padula S, Roselli A, Dominelli V, Cagioli S, Kirchin MA, Pirovano G, Passariello R.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [Abstract] [Full Text] [Related]

  • 40. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM, Nguyen ET, Jaffey J.
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.